Delivery Order SPE2DR25D2001-SPE2DR26FBGA3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,172.67 to AmerisourceBergen Drug Corp for Ropinirole HCL ER 2 mg tablets (90-count supply). This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,373.64 Firm Fixed Price delivery order is for the supply of Ropinirole HCL ER 6 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.94 firm fixed-price delivery order is for the supply of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 MG tablets, a medication commonly used to treat Parkinson's disease and restless leg syndrome. The contract has a firm-fixed price of $1,292.25 and a completion date of June 18, 2025. This contract is not set aside and is open to full and open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,083.84 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 12 mg tablets (30-count packaging) on November 18, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- This federal contract award, valued at $1,584.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ropinirole HCL ER 12 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $5,759.27, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract is for the delivery of Ropinirole HCL ER 6 mg tablets, a medication commonly used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.27 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 4 mg tablets (30-count packaging) under a firm fixed price contract type. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ropinirole HCl ER 6 mg tablets (30-count) with a ceiling value of $1,420.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBGA3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 2 mg tablets (30-count packaging) with a ceiling value of $1,458.49. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of December 18, 2025, and performance will be conducted from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ropinirole is a dopamine agonist commonly prescribed for Parkinson's disease and restless leg syndrome treatment, reflecting the company's role in supplying pharmaceutical products for military and federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle designated SPE2DX and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through competitively awarded contracts across multiple therapeutic domains, serving defense health customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/16/25 |